Literature DB >> 14752525

Molecular genetics of human prostate cancer.

Mark A Rubin1, Angelo M De Marzo.   

Abstract

Multiple factors contribute to the high incidence and prevalence of prostate cancer including race, ethnicity, diet, environment, widespread awareness through prostate-specific antigen screening and genetics. Linkage analysis has identified several candidate sites for hereditary prostate cancer gene loci. Molecular studies have also identified genes that are frequently altered in sporadic prostate cancer. It appears that due to the heterogeneity of prostate cancer, multiple genes may be involved in the neoplastic process.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14752525     DOI： 10.1038/modpathol.3800051

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


  8 in total

1.  Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.

Authors:  Natalay Kouprina; Nicholas C O Lee; Adam Pavlicek; Alexander Samoshkin; Jung-Hyun Kim; Hee-Sheung Lee; Sudhir Varma; William C Reinhold; John Otstot; Greg Solomon; Sean Davis; Paul S Meltzer; Johanna Schleutker; Vladimir Larionov
Journal:  Genes Chromosomes Cancer       Date:  2012-06-26       Impact factor: 5.006

2.  Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.

Authors:  Natalay Kouprina; Adam Pavlicek; Vladimir N Noskov; Greg Solomon; John Otstot; William Isaacs; John D Carpten; Jeffrey M Trent; Joanna Schleutker; J Carl Barrett; Jerzy Jurka; Vladimir Larionov
Journal:  Genome Res       Date:  2005-11       Impact factor: 9.043

3.  Defining aggressive prostate cancer using a 12-gene model.

Authors:  Tarek A Bismar; Francesca Demichelis; Alberto Riva; Robert Kim; Sooryanarayana Varambally; Le He; Jeff Kutok; Jonathan C Aster; Jeffery Tang; Rainer Kuefer; Matthias D Hofer; Phillip G Febbo; Arul M Chinnaiyan; Mark A Rubin
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

4.  Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.

Authors:  Toshiro Migita; Stacey Ruiz; Alessandro Fornari; Michelangelo Fiorentino; Carmen Priolo; Giorgia Zadra; Fumika Inazuka; Chiara Grisanzio; Emanuele Palescandolo; Eyoung Shin; Christopher Fiore; Wanling Xie; Andrew L Kung; Phillip G Febbo; Aravind Subramanian; Lorelei Mucci; Jing Ma; Sabina Signoretti; Meir Stampfer; William C Hahn; Stephen Finn; Massimo Loda
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

5.  Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo.

Authors:  Yizhou Dong; Ahmed A Eltoukhy; Christopher A Alabi; Omar F Khan; Omid Veiseh; J Robert Dorkin; Sasilada Sirirungruang; Hao Yin; Benjamin C Tang; Jeisa M Pelet; Delai Chen; Zhen Gu; Yuan Xue; Robert Langer; Daniel G Anderson
Journal:  Adv Healthc Mater       Date:  2014-03-13       Impact factor: 9.933

6.  Human Prostate Cancer Hallmarks Map.

Authors:  Dipamoy Datta; Md Aftabuddin; Dinesh Kumar Gupta; Sanghamitra Raha; Prosenjit Sen
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

7.  Clinical values of expression signature of circCDR1AS and circHIAT1 in prostate cancer: Two circRNAs with regulatory function in androgen receptor (AR) and PI3K/AKT signaling pathways.

Authors:  Mahsa Aghajani Mir; Hossein Dinmohammadi; Emadoddin Moudi; Nima Motamed; Abdolreza Daraei
Journal:  J Clin Lab Anal       Date:  2022-01-10       Impact factor: 2.352

8.  LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types.

Authors:  Jung H Kim; Alla Karnovsky; Vasudeva Mahavisno; Terry Weymouth; Manjusha Pande; Dana C Dolinoy; Laura S Rozek; Maureen A Sartor
Journal:  BMC Genomics       Date:  2012-10-04       Impact factor: 3.969
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.